10K Filing: Key information on Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. has filed its Form 10-K annual report with the SEC for the period ending September 30, 2024. This filing provides a comprehensive overview of the company’s financial performance and operations, including key information such as their mailing address, business address, and contact information. The filing includes several attachments, such as the annual report, description of common stock, insider trading policy, consent of independent registered public accounting firm, and various certifications, all of which are crucial for investors and stakeholders to assess the company’s standing.
Attachments:
1. Annual Report
2. Description of Common Stock
3. Insider Trading Policy
Additional Information:
– CIK: 0001506251
– IRS No.: 273425913
– State of Incorporation: NV
– Fiscal Year End: 09/30
– SIC: 2834 Pharmaceutical Preparations
– Business Address: 11 Commerce Drive, 1st Floor, Cranford, NJ 07016
– Contact: (908) 967-6676
For a more detailed understanding of Citius Pharmaceuticals, Inc.’s financial and operational performance, interested parties can refer to the complete submission text file available at the following link: Complete submission text file
